Latest Breaking News On - Gyre therapeutics - Page 1 : comparemela.com

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 7 5%

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 7 5%
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesNassim usmanGyre therapeutics incGyre therapeuticsGet free reportDirector nassim usmanMetabolic dysfunction associated steatohepatitisIts hydronidoneGyre therapeutics daily

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesChan yingSan diegoStephen jasperContinent pharmaceuticals co ltdExchange commissionDrug administrationNational medical products administrationGyre therapeutics incGyre pharmaceuticalsPreclinical development updatesClinical development updatesJiangsu wangao pharmaceuticals co ltdChief executive officerIshak scoring systemNon alcoholic steatohepatitis

Catalyst Biosciences : Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K

Catalyst Biosciences : Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesChan yingSan diegoStephen jasperExchange commissionNational medical products administrationClinical development updatesJiangsu wangao pharmaceuticals co ltdGyre therapeutics incContinent pharmaceuticals co ltdPreclinical development updatesGyre pharmaceuticalsDrug administrationGyre therapeutics reports first quarterProvides business updateChief executive officer

Gyre Therapeutics (NASDAQ:GYRE) Shares Up 9 2%

Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)’s share price was up 9.2% during mid-day trading on Thursday . The stock traded as high as $15.72 and last traded at $15.14. Approximately 36,442 shares changed hands during mid-day trading, a decline of 56% from the average daily volume of 82,304 shares. The stock had previously […]

United statesNassim usmanGyre therapeutics incSecurities exchange commissionGyre therapeuticsGet free reportDirector nassim usmanExchange commissionMetabolic dysfunction associated steatohepatitisIts hydronidoneGyre therapeutics daily

Gyre Therapeutics (NASDAQ:GYRE) Trading 9 2% Higher

Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) rose 9.2% on Thursday . The stock traded as high as $15.72 and last traded at $15.14. Approximately 36,442 shares changed hands during mid-day trading, a decline of 56% from the average daily volume of 82,304 shares. The stock had previously closed at $13.86. Gyre […]

United statesNassim usmanGyre therapeutics incSecurities exchange commissionGyre therapeuticsGet free reportDirector nassim usmanExchange commissionMetabolic dysfunction associated steatohepatitisIts hydronidoneGyre therapeutics dailyNasdaq gyre